| Literature DB >> 22443975 |
Leonidas H Duntas1, Gabriela Brenta.
Abstract
Thyroid hormones regulate cholesterol and lipoprotein metabolism, whereas thyroid disorders, including overt and subclinical hypothyroidism, considerably alter lipid profile and promote cardiovascular disease. Good evidence shows that high thyroid-stimulating hormone (TSH) is associated with a nonfavorable lipid profile, although TSH has no cutoff threshold for its association with lipids. Thyromimetics represent a new class of hypolipidemic drugs: their imminent application in patients with severe dyslipidemias, combined or not with statins, will improve the lipid profile, potentially accelerate energy expenditure and, as a consequence, vitally lessen the risk of cardiovascular disease. Copyright ÂEntities:
Mesh:
Substances:
Year: 2012 PMID: 22443975 DOI: 10.1016/j.mcna.2012.01.012
Source DB: PubMed Journal: Med Clin North Am ISSN: 0025-7125 Impact factor: 5.456